Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
SLC25A12 encodes the mitochondrial aspartate–glutamate carrier isoform 1 (AGC1), a neuron- and muscle-specific component of the malate–aspartate NADH shuttle that exports aspartate to the cytosol, supporting mitochondrial oxidation of cytosolic NADH and providing substrates for myelin synthesis.
AGC1 deficiency manifests as developmental and epileptic encephalopathy 39, characterized by arrested psychomotor development, congenital hypotonia (HP:0001252), seizures (HP:0001250), and global cerebral hypomyelination.
In a single patient, a homozygous missense variant c.1769A>G (p.Gln590Arg) abolished AGC1 transport activity and caused the full clinical phenotype ([PMID:19641205]). In a consanguineous Indian family, two siblings with profound developmental delay, hypotonia, refractory epilepsy, hypomyelination, and reduced N-acetylaspartate harbored a homozygous c.1058G>A (p.Arg353Gln) variant with residual activity of 15% ([PMID:24515575]).
Segregation analysis confirmed homozygosity in all affected relatives (affected_relatives: 2), supporting autosomal recessive inheritance.
Functional assays in patient fibroblasts and reconstituted systems demonstrated absent or markedly reduced AGC1 transport for both variants, validating loss of function as the mechanism ([PMID:19641205], [PMID:24515575]).
AGC1 knock-down in oligodendrocyte precursor cells reduced proliferation and induced precocious differentiation via dysregulation of PDGFα and TGFβ signaling, linking AGC1 deficiency to oligodendrocyte dysfunction and hypomyelination ([PMID:31514314], [PMID:38553684]).
Slc25a12-knockout mice exhibit hypomyelination, neurofilament accumulation, and early lethality; slice culture myelination defects were rescued by pyruvate, underscoring impaired aspartate/N-acetylaspartate metabolism and NADH balance in pathogenesis ([PMID:20015484]).
Collectively, three probands across two families and extensive functional concordance support a Moderate clinical validity for SLC25A12 in developmental and epileptic encephalopathy 39. SLC25A12 sequencing should be considered in children with infantile epilepsy, congenital hypotonia, and hypomyelination.
Gene–Disease AssociationModerate3 probands across two families and concordant functional data ([PMID:19641205], [PMID:24515575]) Genetic EvidenceModerateThree probands with homozygous missense variants segregating in an autosomal recessive pattern ([PMID:19641205], [PMID:24515575]) Functional EvidenceStrongMultiple in vitro transport assays abolishing or reducing AGC1 activity, oligodendrocyte precursor cell models, and knockout mouse models demonstrating hypomyelination ([PMID:19641205], [PMID:31514314], [PMID:20015484]) |